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Synthesis and biology of oligoethylene glycol linked naphthoxylosides
Introduction
Proteoglycans (PGs) are macromolecules, usually located in extracellular matrices or associated to cell-surfaces in mammalian cells. They are involved in a diversity of cellular processes such as cell development, differentiation, migration, adhesion, and proliferation. PGs consist of a core protein covalently substituted with one or more linear polyanionic carbohydrate chains, known as glycosaminoglycans (GAG). The GAG chains are assembled on the core protein by xylosylation of a serine residue, followed by attachment of two Gal residues and one GlcA residue, which together constitute a linker tetrasaccharide. Alternating disaccharides are then added to the linker tetrasaccharide, resulting in chondroitin sulfate/dermatan sulfate (CS/DS) or heparin sulfate (HS) GAG chains consisting of repeating -4GlcAβ1-3GalNAcβ1-or -4GlcAβ1-4GlcNAcα1residues, respectively. Subsequent modifications of the carbohydrate backbone, such as epimerization, N-deacetylation, and O-and N-sulfation result in a wide structural diversity, and thus, a considerable amount of biological functions of the GAG chains. [1] [2] [3] Xylose is an unusual carbohydrate in mammalian cells, hitherto only known to serve as an initiator of HS and CS/DS GAG synthesis on the PG core protein. Almost 40 years ago, it was shown that β-D-xylosides exogenously added to cells could act as primers for GAG formation. Xylose, when attached to various hydrophobic aglycons, is able to penetrate plasma membranes and compete with the xylosylated core protein for enzymes and substrates for GAG synthesis. [4] [5] Xyloside-induced GAG priming occurs in a concentration dependent manner, but the efficacy varies widely among different cell types. These variations may be related to the structure of the aglycon, relative abundance of endogenous substrates, enzyme concentrations, the solubility of the xylosides, xyloside-uptake across the plasma
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membrane and into the Golgi apparatus, and the relative affinity of the xylosides for the enzymes involved in the GAG synthesis. The biological effects of different xylosides have been investigated in various experimental systems. For example, inhibition of morphogenesis in various tissues, such as salivary glands, 6 embryonic mouse molars, 7 fetal mouse kidney, 8 and rat nervous tissue, 9 have been observed due to perturbed PG/GAG expression by p-nitrophenyl β-D-xyloside or 4-methylumbelliferyl β-D-xyloside treatment.
The spectrum of possible applications for xylosides is broad. For instance, they have been shown to exhibit (i) antiprion activities, 10 (ii) antithrombotic properties, [11] [12] (iii) inhibiting effects on tumor invasion, (iv) beneficial effects on skin aging, [13] [14] (v) enhancing spinal cord repair after injury, 15 (vi) antiangiogenesis effects, 16 and (vii) tumor selective antiproliferative activities [17] [18] [19] . Recently, we showed that 2-(6hydroxynaphthyl) β-D-xylopyranoside, XylNapOH (1b, Figure  1 ), in contrast to 2-naphthyl β-D-xylopyranoside, XylNap (1a, Figure 1 ), selectively inhibited tumor growth both in vitro and in vivo. 20 XylNapOH-primed GAG chains from cancer cells were internalized both by cancer cells and healthy cells, resulting in apoptotic cells and thereby an antiproliferative effect. In contrast, XylNapOH-primed GAG chains from healthy cells were not internalized and lacked antiproliferative activity. Earlier investigations on the biological effects of xylosides with aromatic aglycons indicate that the sugar residue can be separated from the aromatic aglycon by short linkers, without diminishing the GAG priming ability. 21 To systematically investigate the effects of the xylose-aglycon distance on the GAG priming ability, we have synthesized xylosides with the naphthyl moiety connected to the xylose directly, via a methylene bridge, or with oligoethylene glycol (OEG) linkers of different lengths ( Figure 1 ). This increases the linker surface area of the xylosides and thereby making them more accessible for the enzymes involved in GAG biosynthesis. In addition, we have included 6hydroxynaphthyl analogs, since the presence of a hydroxyl group in position 6 of the naphthol has been shown to result in significant anti-tumor effects. 20 Interestingly, we have previously shown that hydroxylation of only some of the positions in the aromatic system, e.g. position 6, leads to selective tumor toxicity. 22 Thus, we present a model system where the xylose residue is separated from the aromatic moiety, i.e. 2-naphthyl or 2-(6-hydroxynaphthyl), with linkers of different lengths, thus increasing the xylose-aglycon distance from approx. 0.2 up to 1.3 nm. OEG linkers were chosen since they are available in different lengths, they induce water solubility, and they are inexpensive. The model system, visualized by compounds 1a and 5, is shown in Figure 2 . We have investigated the biological effects of the xylosides in terms of GAG priming ability and antiproliferative activity using human breast fibroblasts, CCD-1095Sk cells, and human breast carcinoma cells, HCC70 cells.
Results and discussion
Synthesis
Compounds 2a 23 , 3a 21 , and 8 24 have been published before, however, full physical characterization has not been reported, and hence syntheses and analyses are described herein.
2-Naphthalenemethyl xylosides 2a-b were synthesized from peracetylated xylose 6 via the acetate protected xylosides 7a-b (Scheme 1). Synthesis of 7a using 2-naphthalenemethanol was problematic, generating impurities inseparable from the desired product. Therefore, deacetylation using standard Zemplén conditions was performed yielding xyloside 2a without isolation of compound 7a. Formation of 7b on the other hand was straightforward, using 6-acetoxy-2-naphthalenemethanol to obtain compound 7b in 79% yield. Deacetylation of 7b generated xyloside 2b in good yield. Scheme 1. Reagents and conditions: i) 6 (1.2 eq), 2-naphthalenemethanol (1 eq), BF3⋅Et2O (1.5 eq), CH2Cl2, 0 °C, 7a (not isolated); 6 (1.2 eq), 6acethoxy-2-naphthalenemethanol (1.5 eq), BF3⋅Et2O (1.5 eq), CH2Cl2, 0 °C, R 7b (79%); ii) NaOMe (0.05 M), MeOH, 2a (11% over two steps), 2b (68%); iii) 6 (1.2 eq), 2-bromoethanol (1 eq), BF3⋅Et2O (1.5 eq), CH2Cl2, 0 °C, 8 (69%); 6 (1.2 eq), 2-(2-chloroethoxy)-ethanol (1 eq), BF3⋅Et2O (1.5 eq), CH2Cl2, 0 °C, 9 (43%); 6 (1.2 eq), 2-[2-(2-chloroethoxy)ethoxy]-ethanol (1 eq), BF3⋅Et2O (1.5 eq), CH2Cl2, 0 °C, 10 (61%); iv) 2-Naphthol (2 eq), K2CO3 (1.2 eq), DMF, 80 °C, 11a (63%); 6-acetoxy-2-naphthol (2 eq), K2CO3 (1.2 eq), DMF, 80 °C, 11b (not isolated); 2-Naphthol (2 eq), K2CO3 (1.2 eq), 18crown-6 (10 eq), DMF, 80 °C, 12 (22%), 13 (29%); v) NaOMe (0.05 M), MeOH, 3a (90%), 3b (39% over two steps), 4 (73%), 5 (66%).
The syntheses of xylosides 3-5 started from peracetylated xylose 6, which was reacted with OEG linkers of three different lengths to form compounds 8-10. For the shortest linker, 2-bromoethanol was used. For the linkers containing diethylene glycol and triethylene glycol units, the bromide analogs were not commercially available, hence the chloride analogs were used. The coupling of 2-naphthol to 9 and 10, respectively, to generate compounds 12 and 13 caused some difficulties, whereas the reaction to form 11a was straightforward. This might have been a result of the weaker leaving group property of chloride compared to bromide. In addition, the longer OEG linker could theoretically coordinate a potassium ion to form crown ether-like complex. To avoid this, 18-crown-6 was added to the reaction mixtures, resulting in an increase in yield of 13 from trace amounts to approximately 30%. Furthermore, the reaction times for both 12 and 13 were considerably decreased, from 48 hours to 6 hours.
The coupling of 6-acetoxy-2-naphthol to 8 proceeded smoothly, but 11b could not be isolated, since the aromatic acetate was cleaved off during the reaction and the mixture was thus deacetylated to obtain xyloside 3b. Deacetylation of 11a, 12, and 13 generated xylosides 3a, 4, and 5 in good yields.
The distances between the anomeric carbon and the aromatic carbon connected to the linker were calculated using density functional theory at the B3LYP/6-31G** level and default settings in Spartan '10 for Macintosh (Table 1) . 25 Ethylene glycol linkers are often preferred over aliphatic linkers due to the oxygen atoms that counterbalance the unpolar hydrocarbon parts of the linker. The gradient HPLC retention times, which can be used to substitute log P values, 26 were measured for the xylosides using a C-18 column and a mobile phase of water (0.1% TFA) with a gradient of MeCN from 1 minute increasing by 1.2% per minute ( Table 1 ). The retention times increased with increasing xylose-aglycon distances, which probably is a combined effect of a slightly decreased polarity and increased surface area of the xylosides. The two series, naphthyl xylosides 1a, 2a, 3a, 4, and 5, and hydroxynaphthyl xylosides 1b, 2b, and 3b, show considerable differences in retention times, indicating the importance of the aromatic hydroxyl group on polarity. 
Biology
To investigate the ability of the xylosides to induce GAG priming, human breast fibroblasts (CCD-1095Sk cells) and human breast carcinoma cells (HCC70 cells) were treated with 100 µM of the xylosides in low-sulfate medium supplemented with [ 35 S]sulfate for 24 h. [ 35 S]Sulfate-labeled polyanionic material from culture media was then isolated by ion exchange chromatography and hydrophobic interaction chromatography. The isolated material was further separated based on size by gel permeation FPLC on a Superose 6 column. As shown in Table 2 and Figure 3 , treatment with the xylosides resulted in GAG priming in both CCD-1095Sk cells and HCC70 cells (data can be found as supplementary data). The level and the Superose 6 profile of GAG priming for compounds 1a and 1b were in agreement with previously published data. 18 In general, the level of [ 35 S]sulfate-incorporation was lower in untreated CCD-1095Sk cells than in untreated HCC70 cells. However, when treated with xylosides the level of [ 35 S]sulfateincorporation was higher in CCD-1095Sk cells than in HCC70 cells, indicating a higher level of GAG priming, or a higher level of sulfation of GAG chains in the CCD-1095Sk cells. In addition, the xyloside-primed GAG chains synthesized in CCD-1095Sk cells were, on average, somewhat longer than those synthesized in HCC70 cells ( Table 2 , see peak maximum). Furthermore, the primed GAG chains induced by the hydroxynaphthyl xylosides 1b, 2b and 3b, were, on average, slightly shorter than those from the corresponding naphthyl xylosides 1a, 2a, 3a, 4 and 5, in both cell lines ( Table 2 , see peak maximum).
An increase in xylose-aglycon distance from 0.24 nm to 0.37 nm resulted in an increased GAG priming ability in both cell lines (Figure 4 ), probably due to an increased surface area of the xylosides, making them more accessible for the enzymes involved in the GAG synthesis. Further increase in the xylose-aglycon distance did not enhance the level of primed GAG chains, except for the naphthyl xylosides in CCD-1095Sk cells where the level of GAG priming increased with increasing xylose-aglycon distance up to 0.60 nm and then reached a plateau. Such a trend was not found in HCC70 cells for naphthyl xylosides and these differences can be explained either by different GAG synthesis machinery in the two cell types, or by different uptake and/or internal distribution of the xylosides. In both cell lines the hydroxynaphthyl xylosides show a somewhat higher degree of priming, compared to the compounds without a 6-hydroxyl group. To investigate the composition of the xyloside-primed material, Superose 6 fractions 35-51 for HCC70 cells, as well as fractions 34-51 for CCD-1095Sk cells, were pooled and subjected to HNO 2 pH 1.5 degradation, followed by size separation on Superose 6 column. Remaining undigested material was either pooled and subjected to chondroitin ABC lyase digestion, followed by size separation on Superose 6, or presumed to contain only CS/DS (data not shown). As shown in Table 3 , treatment with HNO 2 pH 1.5 resulted in partial degradation of the subjected material. Digestions with chondroitin ABC lyase resulted in complete degradation of the subjected material (data not shown). Together, this indicates that secreted xyloside-primed materials were composed of both HS and CS/DS GAG chains. The proportion of xyloside-primed HS was higher in HCC70 cells than in CCD-1095Sk cells, except for compound 5. Furthermore, the hydroxynaphthyl xylosides resulted in higher proportions of HS priming compared to the naphthyl xylosides (Table 3 ). As determined from Tables 2 and  3 , no correlation between the proportion of HS and the total amount of primed material could be observed. In addition, there was no obvious correlation between the xylose-aglycon distance and the proportion of HS. Fritz and co-workers have previously shown that both compounds 1a and 3a induce priming of HS to the same extent in CHO cells. 21 They also showed that an increase of the distance between the aglycon and the xylose with an unpolar linker, i.e. 4-(2-naphthoxy)-1-butyl β-D-xyloside, resulted in decreased proportion of HS synthesis. This is in agreement with our data, since compound 4, which similarly to their hydroxybutyl-linked xyloside also had a lower amount of HS compared to compounds 1a and 3a. In addition, they found no correlation between partitioning of xylosides in octanol-water and HS priming ability, which is also verified by our data.
To determine the antiproliferative activity, CCD-1095Sk cells and HCC70 cells were incubated with increasing concentrations of the xylosides (5-500 µM) for 96 h. Cell proliferation was recorded using the crystal violet method, and the antiproliferative effect expressed as ED 50 (µM) ( Table 4 ). Only compound 3b and the previously published compound 1b were selectively toxic towards the HCC70 cells. However, in these experiments the HCC70 cells were much less sensitive towards 3b compared to 1b. We have earlier shown 1b to be tumor selective both in vivo and in vitro and in several different cell lines. Interestingly, in HCC70 cells the antiproliferative effects of most compounds were correlated to the xylose-aglycon distances, and thus the polarity ( Figure 5 ). With the exception of the tumor-selective compound 1b, longer linkers and thus less polar compounds showed a stronger effect as compared to the shorter and more polar ones. In CCD-1095Sk cells, a correlation between the xylose-aglycon distance and the antiproliferative activity was less pronounced but the general trend was similar. Furthermore, in none of the cell lines, correlations between the antiproliferative activity and the aglycon structure, the GAG priming ability, or the HS proportion could be deduced. 
Conclusions
We have synthesized xylosides separated from a 2-naphthyl aglycon by distances from 0.24 to 1.31 nm. In addition, we have synthesized analogs to the naphthyl xylosides with 2-(6hydroxynapthyl) aglycons. By increasing the xylose-aglycon distance from 0.24 nm to 0.37 nm, enhancement of the GAG priming ability was observed. It is reasonable that an increase in the xylose-aglycon distance, and thereby the accessibility of the xylose, to a certain level would facilitate binding of xylose by enzymes involved in the GAG synthesis. Additionally, xylosides with even longer xylose-aglycon distances resulted in an increase of the GAG priming ability in normal cells, whereas the effect was omitted in tumor cells. Furthermore, upon xylosidetreatment CCD-1095Sk cells expressed higher total levels of GAG chains, or higher degree of sulfations, compared to HCC70 cells. HCC70 cells, on the other hand, expressed higher levels of HS GAGs in the presence of the xylosides than CCD-1095Sk cells, indicating that the cell type and relative abundance of endogenous substrates and enzymes are relevant for the GAG composition. According to our results, the hydroxynaphthyl xylosides induced a somewhat higher degree of GAG priming, compared to the naphthyl xylosides. Furthermore, treatment with the hydroxynaphthyl xylosides resulted in higher proportions of HS priming compared to the naphthyl ones. Taken together, these results suggest that the biosynthesis of xyloside-primed GAG chains is dependent on the cell type and the aglycon structure. No correlations between the antiproliferative activity and the amounts or compositions of the GAG chains were detected. Compound 1b was unique in that it showed a tumor-selective toxicity, suggesting involvement of other factors such as fine structure of the GAG chains, effects on endogenous PG synthesis or other unknown factors for the antiproliferative activity. Future investigations will focus on the origin of this selectivity.
Experimental section
Synthesis
All solvents were dried using MBRAUN SPS-800 Solvent purification system prior to use, unless otherwise stated. The purchased reagents were used without further purification. NMRspectra were recorded on a Bruker Avance II at 400 MHz ( 1 H) and 100 MHz ( Synthesis and physical characterization of compound 1a has been described. 21 A simplified synthetic route was used that comprised treatment of a mixture of 1,2,3,4-tetra-O-acetyl-β-Dxylopyranose and 2-naphthol in CH 2 Cl 2 with BF 3 ⋅OEt 2 followed by de-O-acetylation using standard Zemplén conditions. Synthesis of 1b has been described in detail previously. 27 The analyses of the products were in accordance with published data.
(2-Naphthyl)-methyl β-D-xylopyranoside (2a)
Peracetylated xylose 6 (319 mg, 1.00 mmol) and 2naphthalenemethanol (273 mg, 1.50 mmol) were dissolved in CH 2 Cl 2 (3 mL) and BF 3 ⋅Et 2 O (190 µL, 1.50 mmol) was added dropwise to the solution at 0 °C. The mixture was allowed to reach rt and stirred for 1.5 hour. CH 2 Cl 2 was added and the mixture was washed with water (20 mL) and NaHCO 3 (sat. aq.) (20 mL). The organic layer was dried over Na 2 SO 4 , filtered and concentrated to yield a white solid. The crude was filtered through a pile of silica, concentrated, and used in the next step without further purification.
The crude residue (344 mg) was dissolved in MeOH/CH 2 Cl 2 (1:1, 6 mL) and NaOMe (1 M, 0.3 mL) was added. After 1.5 h of stirring at rt, AcOH (6 mL) was added and the reaction mixture was concentrated to yield a white solid. HPLC gave 2a after lyophilization as a white solid (33 mg, 11%). 
(2-(6-Hydroxy-naphthyl))-methyl β-D-xylopyranoside (2b)
Acetoxynaphthyl xyloside 7b (87 mg, 0.18 mmol) was dissolved in MeOH (8 mL) and NaOMe (1 M, 0.4 mL) was added. After 1.5 h of stirring at rt, AcOH (8 mL) was added and the reaction mixture was concentrated to yield a white solid. HPLC gave 2b after lyophilization as a white solid (39 mg, 68%). 
2-(2-Naphthoxy)-1-ethyl β-D-xylopyranoside (3a)
Synthesized using similar conditions as for 2b. Naphthyl xyloside 11a (66 mg, 0.15 mmol) gave 3a after HPLC and lyophilization as a white solid (43 mg, 90%). 
2-(6-Hydroxy-2-naphthoxy)-1-ethyl β-D-xylopyranoside (3b)
A suspension of 6-acetoxy-2-naphthol (97 mg, 0.48 mmol) and K 2 CO 3 (40 mg, 0.29 mmol) in DMF (2 mL) was stirred for 1 h before xyloside 8 (100 mg, 0.261 mmol) was added. The reaction mixture was heated to 80 °C for 1 hour and worked-up as for 11a. The crude was filtered through a pile of silica, concentrated, and used in the next step without further purification.
The crude residue (76 mg) was dissolved in MeOH/CH 2 Cl 2 (1:1, 4 mL) and NaOMe (1 M, 0.2 mL) was added. After 1.5 h of stirring at rt, AcOH (4 mL) was added and the reaction mixture was concentrated to yield a white solid. HPLC gave 3b after lyophilization as a white solid (34 mg, 39%). 
5-(2-Naphthoxy)-3-oxo-1-pentyl β-D-xylopyranoside (4)
Synthesized using similar conditions as for 2b. Naphthyl xyloside 12 (32 mg, 0.065 mmol) gave 4 after HPLC and lyophilization as a white solid (17 mg, 73% 
8-(2-Naphthoxy)-3,5-dioxo-1-octyl β-D-xylopyranoside (5)
Synthesized using similar conditions as for 2b. Naphthyl xyloside 13 (22 mg, 0.041 mmol) gave 5 after HPLC and lyophilization as a colorless oil (11 mg, 66% 
(2-(6-Acetoxy)-naphthyl)-methyl 2,3,4-tri-O-acetyl-β-Dxylopyranoside (7b)
Peracetylated xylose 6 (119 mg, 0.374 mmol) and 6-acethoxy-2-naphthalenemethanol 28 24 Peracetylated xylose 6 (1.16 g, 3.64 mmol) was dissolved in CH 2 Cl 2 (10 mL) and 2-bromoethanol (215 µL, 3.03 mmol) was added. BF 3 ⋅Et 2 O (570 µL, 4.49 mmol) was added dropwise to the solution at 0 °C. The mixture was allowed to reach rt and stirred for 1.5 hour. CH 2 Cl 2 was added and the mixture was washed with water (20 mL) and NaHCO 3 (sat. aq.) (20 mL). The organic layer was dried over Na 2 SO 4 , filtered and concentrated to yield an off-white solid. Column chromatography (SiO 2 , 1:25 → 1:10 EtOAc/CH 2 Cl 2 ) gave 8 as a white solid (801 mg, 69% 1.10 5-Chloro-3-oxo-1-pentyl 2,3,4 
2-Bromoethyl 2,3,4-tri-O-acetyl-β-D-xylopyranoside (8)
-tri-O-acetyl-β-D-xylopyranoside (9)
Peracetylated xylose 6 (383 mg, 1.20 mmol) was dissolved in CH 2 Cl 2 (3 mL) and 2-(2-chloroethoxy)-ethanol (106 µL, 1.00 mmol) was added. BF 3 
2-(2-Naphthyloxy)-1-ethyl 2,3,4-tri-O-acetyl-β-D-xylopyranoside (11a)
A suspension of 2-naphthol (75 mg, 0.52 mmol) and K 2 CO 3 (41 mg, 0.30 mmol) in DMF (2 mL) was stirred for 1 h before xyloside 8 (100 mg, 0.263 mmol) was added. The reaction mixture was heated to 80 °C over night before it was allowed to reach rt and water (5 mL) was added. The water phase was extracted with EtOAc (3 x 10 mL), and the combined organic layers were washed with brine (40 mL), dried over Na 2 SO 4 , filtered and concentrated to yield a brown solid. Column chromatography (SiO 2 , 1:2 EtOAc/heptane) gave 11a as an offwhite solid (75 mg, 63%). 
